Business Context and Reporting Period
This Form 6-K filing by GSK plc covers the month of July 2026, with a report date of July 14, 2026. The document serves as a transaction notification detailing share acquisitions by Persons Discharging Managerial Responsibilities (PDMRs) and Persons Closely Associated (PCAs). The transactions primarily involve the re-investment of dividends paid on July 9, 2026, into Ordinary Shares or American Depositary Shares (ADS).
Key Financial Metrics and Transaction Details
The filing does not contain corporate financial statements, revenue, profit, cash flow, or debt metrics. It exclusively reports on specific share transactions executed by senior executives.
| Transaction Type | Instrument | Price | Volume Range | Date |
|---|---|---|---|---|
| Dividend Re-investment | Ordinary Shares | £19.6297 | 20.727 to 5,803.725 | 2026-07-09 |
| Deferred Bonus Plan | Ordinary Shares | £19.5950 | 115 to 1,636 | 2026-07-10 |
| Deferred Bonus Plan | ADS | $52.4700 | 324 | 2026-07-10 |
| ISA Re-investment | Ordinary Shares | £19.7550 | 6 to 18 | 2026-07-13 |
Material Changes
The filing does not provide comparative financial data or material changes to the company's business operations. The only changes reported are the incremental increases in shareholdings for the listed executives resulting from dividend re-investment plans and deferred bonus schemes.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a statutory disclosure of insider trading activity compliant with Rule 13a-16 or 15d-16.
Key Facts for Investor Verification
- Dividend Payment Date: Confirm the dividend payment date of July 9, 2026, aligns with the company's declared dividend schedule.
- Share Price Consistency: Verify that the transaction prices (£19.5950 to £19.7550) reflect the market price on the London Stock Exchange (XLON) and New York Stock Exchange (XNYS) for the respective dates.
- Executive Participation: Note that all listed transactions are acquisitions (buys) via automatic re-investment, indicating no voluntary sales by senior leadership during this period.
- Instrument Types: Distinguish between direct Ordinary Share acquisitions and notional interest increases in the Deferred Annual Bonus Plan.